Skip to main content
. 2018 Nov 27;10(12):669. doi: 10.3390/v10120669

Figure 3.

Figure 3

Investigation of RC’s antiviral effect on HCV entry. (A) Synchronized infection analysis of RC treatment on HCV early viral entry. (B) Validation of RC’s inhibitory activity against HCV attachment using ELISA-based virus binding assay. (C) Impact of RC treatment on HCVpp infection of Huh-7.5 cells. (D) Western blot analysis of RC treatment effect on HCV host cell entry factors. Data represent means ± SEM from 3 independent experiments. RC = 20 μg/mL unless otherwise indicated; DMSO = 0.5 %; *p < 0.05, **p < 0.01, ***p < 0.001. For Western blot analysis, representative blots from 3 independent experiments are shown. β-actin served as loading control.